Characteristics | Number (%) (N = 102) |
---|---|
Gender | |
 Female | 52 (50.98) |
 Male | 50 (49.02) |
Age | |
  < 45 years | 36 (35.29) |
 45–60 years | 40 (39.22) |
  > 60 years | 26 (25.49) |
Comorbidities | |
 No | 74 (72.55) |
 Yes | 28 (27.45) |
Metastatic disease | Â |
 No | 71 (69.61) |
 Yes | 31 (30.39) |
Neoadjuvant chemoradiation | |
 No | 33 (32.35) |
 Yes, a short course | 21 (20.59) |
 Yes, a long course | 48 (47.06) |
Clinical Stage of disease | |
 Stage 1 | 6 (5.88) |
 Stage 2 | 10 (9.80) |
 Stage 3 | 59 (57.84) |
 Stage 4 | 27 (26.47) |
Adjuvant therapy | |
 Not applicable | 13 (12.75) |
 No | 27 (39.22) |
 Yes | 62 (60.78) |